Outlook Therapeutics, Inc. (OTLK)
$0.56-5.08%Close
SELLCRISIS · day 12
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $23M
- Beta
- 0.75
- P/E (TTM)
- -0.30
- Short % float
- 118.41%
- Days to cover
- 7.1
- SI change
- -1.0%
- 1W
- -1.75%
- 1M
- -12.50%
- vs SPY 1W
- -1.62%
- vs SPY 1M
- -15.01%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on OTLK?
- LOPJLB’s latest quantitative signal on Outlook Therapeutics, Inc. (OTLK) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is OTLK in?
- Outlook Therapeutics, Inc. (OTLK) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Outlook Therapeutics, Inc. (OTLK) do?
- Outlook Therapeutics, Inc. is a biopharmaceutical company in the advanced stages of clinical development, focused on inventing and bringing to market monoclonal antibody treatments for various eye conditions. Its flagship drug candidate, ONS-5010, is an ophthalmic formulation of bevacizumab currently undergoing crucial Phase III clinical trials. This investigational product is being evaluated f…